Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
KOSE Corp to Establish Joint Venture with Elder Pharmaceuticals Ltd
KOSE Corp announced that it has decided to establish an India-based joint venture called KOSE Elder (India) Private Limited, which will be engaged in the manufacturing, import and wholesale of cosmetics, with an India-based medicine maker Elder Pharmaceuticals Limited, in September 2013. KOSE and Elder Pharmaceuticals will each hold a 60% and 40% stake in KOSE Elder (India) Private Limited, respectively.
Latest Developments for Elder Pharmaceuticals Ltd
- Elder Pharmaceuticals Ltd Decides Not To Proceed With Amalgamation Of Elder Health Care Ltd
- Elder Pharmaceuticals Ltd Announces MOU For Establishing JVC
- Elder Pharmaceuticals Limited Plans To Enter Japan This Fiscal-Business Line
- Elder Pharmaceuticals Limited Recommends Dividend; Appoints Joint Managing Director
Latest Key Developments in Pharmaceuticals
- AmerisourceBergen Corp Reaffirms FY 2013 EPS Gudiance-Conference Call
- Immunotec Inc Announces New CEO
- Novo Nordisk A/S Reports Positive Results from First Phase 3 Trial with Long-Acting Factor IX for Treatment of Haemophilia B
- Sanofi SA Announces Positive Results on Pivotal Study of Inhibitor in Myelofibrosis-DJ
- Share this
- Link this
- Digg this
Follow Reuters